Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 461-464, March 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, U.

Factors Controlling Metastasis of Experimental Breast Cancer1

Untae Kim

Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York

Rats bearing a large mammary adenocarcinoma, induced by methylcholanthrene (MCA), whether it is an autochthonous or a transplanted isologous tumor, often had an enlarged spleen without metastatic involvement of any organs. Such spleens contained many tumor cells in the venous sinuses. When blood and spleen-mince obtained from the tumor host were inoculated separately into the peritoneal cavity of young adult isologous rats, they produced numerous tumor nodules in the abdomen in all rats. It was concluded, therefore, that the rationale for not finding metastasis in the rat bearing an MCA-induced mammary tumor is in the host immune state evoked by the strong specific antigenicity of the tumor. The possible mechanism controlling metastasis of breast cancer is also discussed.

1 Supported in part by a grant from the Hartford Foundation and Contract SA-43-ph-2398 with the Cancer Chemotherapy National Service Center, National Cancer Institute, NIH.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.